Published :
Tables : 150
Figures : 46
Category : Healthcare
No. of Pages : 220
Report Code : HC-1165
Radiotherapy Market Introduction Radiotherapy market is forecasted to value over USD 8.6 billion by 2027 end and register a CAGR of over 6.2% from the forecast period 2020-2027. Improvements and further amendments in image-guided radiotherapy are propelling the market. The rising preference towards radiotherapy procedures for cancer treatment coupled with increasing usage of particle therapy for cancer diagnosis is spurring the market growth. Latest technological advancements in radiotherapy are expected to propel the market. Furthermore, rising incidences of cancer have expanded the market. According to the American Cancer Society, in 2020, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. The rise in research and development activities regarding cancer treatment launched by non-government and government organizations is expected to boost the market. The market is classified into product type, type, application, end-user, and region. In terms of type, the market is segmented into radiotherapy, internal beam radiotherapy, systemic radiotherapy, and external beam radiotherapy. External beam radiotherapy is expected to achieve high growth owing to the latest advancements in particle beam therapy. Growing research activities related to the field of radiation oncology is expected to propel the market. Based on product type, external beam radiotherapy is expected to achieve the highest growth owing to the affordable cost of equipment of linear accelerator. The 360-degree radiation treatment offered by tomotherapy is adding further growth opportunities thus spurring the market. Based on application, the prostate cancer segment of external beam radiotherapy market holds a vast share of the market. The rising cases of prostate cancer coupled with high success rates of external beam radiotherapy are expected to escalate the market. Moreover, the minimum long term risks associated with external beam radiotherapy is expected to positively influence the market. On the basis of end-user, hospital segment is expected to hold the major market share. Rising healthcare infrastructure and easy access and availability of advanced equipment have expanded the market. The rising cases of cancer globally has resulted in more deployment of hospitals, thus accelerating the market growth. Based on regions, North America dictates the market growth. Presence of prominent players and developed healthcare infrastructure is boosting the market in the region. Growing cases of cancer and favorable government policies are promoting adoption of radiotherapy, thus positively influencing the market. Asia-Pacific region is expected to be a lucrative region for manufacturers owing to a rapidly improving healthcare infrastructure and growing per capita income in emerging economies like China, Japan and India. In addition, favorable policies launched by the governments of these countries is expected to strengthen market position in the region. Major players of the market are Hitachi Ltd., IsoRay Medical, Inc, Ion Beam Applications SA, Provision Healthcare, Varian Medical Systems, Inc, Mevion Medical Systems, Inc, Panacea Medical Technologies Pvt.Ltd, Accuray Incorporated, Elekta AB, ISORAY MEDICAL, INC., NORDION, INC., VARIAN MEDICAL SYSTEMS, INC. Competitive Landscape: ● Varian Medical Systems in 2017, opened its centre in Jundiai, Brazil. The move will increase the access to advanced radiotherapy equipment and treatment across Brazil ● Varian Medical Systems launched an innovative treatment platform called Halcyon Treatment System. The system eases treatment delivery with increased speed and high-quality plans ● Mitsubishi Electric in 2017 decided to transfer its particle therapy systems to Hitachi Radiotherapy Market Segmentation By Product Type External Beam Radiotherapy Linear Accelerators Particle Therapy System Conventional Cobalt-60 Teletherapy Units Internal Beam Radiotherapy/Brachytherapy Seeds Applicators Afterloaders Electronic Brachytherapy Products Systemic Radiotherapy Iobenguane (I-131) Samarium-153 Rhenium-186 By Type External Beam Radiotherapy Image-Guided Radiotherapy 3d Conformal Radiotherapy Intensity-Modulated Radiotherapy Stereotactic Therapy Particle Therapy Internal Beam Radiotherapy Low-Dose-Rate Brachytherapy High-Dose-Rate Brachytherapy Pulsed-Dose-Rate Brachytherapy Systemic Radiotherapy Intravenous Radiotherapy Oral Radiotherapy Instillation Radiotherapy By Application External Beam Radiation Therapy Prostate Cancer Breast Cancer Lung Cancer Head and Neck Cancer Colorectal Cancer Other Cancers Internal Beam Radiotherapy/Brachytherapy Prostate Cancer Gynecological Cancer Breast Cancer Cervical Cancer Penile Cancer Other Cancers By End User Hospital Independent Radiotherapy Centers By Region North America Europe Asia Pacific Latin America Rest of the World FutureWise Key Takeaways ● Growth Prospects ● SWOT Analysis ● Key Trends ● Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on radiotherapy the market by type, by product type, by application, by end-user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Radiotherapy market is forecasted to value over USD 8.6 billion by 2027 end and register a CAGR of over 6.2% from the forecast period 2020-2027.
Improvements and further amendments in image-guided radiotherapy are propelling the market. The rising preference towards radiotherapy procedures for cancer treatment coupled with increasing usage of particle therapy for cancer diagnosis is spurring the market growth. Latest technological advancements in radiotherapy are expected to propel the market. Furthermore, rising incidences of cancer have expanded the market. According to the American Cancer Society, in 2020, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. The rise in research and development activities regarding cancer treatment launched by non-government and government organizations is expected to boost the market.
The market is classified into product type, type, application, end-user, and region. In terms of type, the market is segmented into radiotherapy, internal beam radiotherapy, systemic radiotherapy, and external beam radiotherapy. External beam radiotherapy is expected to achieve high growth owing to the latest advancements in particle beam therapy. Growing research activities related to the field of radiation oncology is expected to propel the market.
Based on product type, external beam radiotherapy is expected to achieve the highest growth owing to the affordable cost of equipment of linear accelerator. The 360-degree radiation treatment offered by tomotherapy is adding further growth opportunities thus spurring the market.
Based on application, the prostate cancer segment of external beam radiotherapy market holds a vast share of the market. The rising cases of prostate cancer coupled with high success rates of external beam radiotherapy are expected to escalate the market. Moreover, the minimum long term risks associated with external beam radiotherapy is expected to positively influence the market.
On the basis of end-user, hospital segment is expected to hold the major market share. Rising healthcare infrastructure and easy access and availability of advanced equipment have expanded the market. The rising cases of cancer globally has resulted in more deployment of hospitals, thus accelerating the market growth.
Based on regions, North America dictates the market growth. Presence of prominent players and developed healthcare infrastructure is boosting the market in the region. Growing cases of cancer and favorable government policies are promoting adoption of radiotherapy, thus positively influencing the market.
Asia-Pacific region is expected to be a lucrative region for manufacturers owing to a rapidly improving healthcare infrastructure and growing per capita income in emerging economies like China, Japan and India. In addition, favorable policies launched by the governments of these countries is expected to strengthen market position in the region.
Major players of the market are Hitachi Ltd., IsoRay Medical, Inc, Ion Beam Applications SA, Provision Healthcare, Varian Medical Systems, Inc, Mevion Medical Systems, Inc, Panacea Medical Technologies Pvt.Ltd, Accuray Incorporated, Elekta AB, ISORAY MEDICAL, INC., NORDION, INC., VARIAN MEDICAL SYSTEMS, INC.
Competitive Landscape: ● Varian Medical Systems in 2017, opened its centre in Jundiai, Brazil. The move will increase the access to advanced radiotherapy equipment and treatment across Brazil ● Varian Medical Systems launched an innovative treatment platform called Halcyon Treatment System. The system eases treatment delivery with increased speed and high-quality plans ● Mitsubishi Electric in 2017 decided to transfer its particle therapy systems to Hitachi Radiotherapy Market Segmentation
By Product Type
By Type
By Application
By End User
By Region
FutureWise Key Takeaways ● Growth Prospects ● SWOT Analysis ● Key Trends ● Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on radiotherapy the market by type, by product type, by application, by end-user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Radiotherapy Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Radiotherapy Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Radiotherapy Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Radiotherapy Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Radiotherapy Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. External Beam Radiotherapy 7.1.1. Linear Accelerators 7.1.2. Particle Therapy System 7.1.3. Conventional Cobalt-60 Teletherapy Units 7.2. Internal Beam Radiotherapy/Brachytherapy 7.2.1. Seeds 7.2.2. Applicators 7.2.3. Afterloaders 7.2.4. Electronic Brachytherapy Products 7.3. Systemic Radiotherapy 7.3.1. Iobenguane (I-131) 7.3.2. Samarium-153 7.3.3. Rhenium-186 8. Global Radiotherapy Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. External Beam Radiotherapy 8.1.1. Image-Guided Radiotherapy 8.1.2. 3d Conformal Radiotherapy 8.1.3. Intensity-Modulated Radiotherapy 8.1.4. Stereotactic Therapy 8.1.5. Particle Therapy 8.2. Internal Beam Radiotherapy 8.2.1. Low-Dose-Rate Brachytherapy 8.2.2. High-Dose-Rate Brachytherapy 8.2.3. Pulsed-Dose-Rate Brachytherapy 8.3. Systemic Radiotherapy 8.3.1. Intravenous Radiotherapy 8.3.2. Oral Radiotherapy 8.3.3. Instillation Radiotherapy 9. Global Radiotherapy Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. External Beam Radiation Therapy 9.1.1. Prostate Cancer 9.1.2. Breast Cancer 9.1.3. Lung Cancer 9.1.4. Head and Neck Cancer 9.1.5. Colorectal Cancer 9.1.6. Other Cancers 9.2. Internal Beam Radiotherapy/Brachytherapy 9.2.1. Prostate Cancer 9.2.2. Gynecological Cancer 9.2.3. Breast Cancer 9.2.4. Cervical Cancer 9.2.5. Penile Cancer 9.2.6. Other Cancers 10. Global Radiotherapy Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Hospital 10.2. Independent Radiotherapy Centers 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1. Hitachi Ltd. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. IsoRay Medical 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Ion Beam Applications SA 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Provision Healthcare 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5.Varian Medical Systems, Inc 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6.Mevion Medical Systems 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7.Panacea Medical Technologies Pvt.Ltd 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Accuray Incorporated 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Elekta AB 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. ISORAY MEDICAL,INC 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11. NORDION, INC 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12. VARIAN MEDICAL SYSTEMS, INC. 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics